Current News

HDMA Statement on Senate HELP Committee Markup of Federal Pharmaceutical Traceability Legislation

HDMA Applauds Passage of Federal Pharmaceutical Traceability Legislation by House Energy and Commerce Committee

HDMA Statement on Federal Pharmaceutical Traceability Legislation

HDMA Applauds White House 2013 National Drug Control Strategy

 

Visit HDMA News Center >


print page

 


 

 

Speeches and Testimony

HDMA Testifies Before House Energy and Commerce Subcommittee on Health
April 25, 2013

Testimony of John M. Gray, President and CEO, Before the Senate Commerce, Science and Transportation Committee (PDF: 73k)
July 25, 2012

HDMA Testifies Before House Energy and Commerce Subcommittee on Health (PDF: 343k)
March 8, 2012

HDMA’s John M. Gray Testifies Before Congress on Prescription Drug Diversion (PDF: 290k)
March 1, 2012

Testimony before the House Energy and Commerce Committee Subcommittee on Health United States House of Representatives, by John M. Gray, President and CEO Healthcare Distribution Management Association (HDMA) (PDF: 42K)
September 23, 2011

Wholesale Distributor Perspectives on the Proposed Class-Wide REMS for Opioids At the FDA Public Meeting on Risk Evaluation and Mitigation Strategies for Certain Opioid Drugs, by Anita T. Ducca Senior Director, Regulatory Affairs Healthcare Distribution Management Association (HDMA)
May 27 and 28, 2009

 
© Copyright Healthcare Distribution Management Association.
All rights reserved.
HDMA: M | C | D
Do you have suggestions
for our site?
URL: